Meet one of the first CRISPR Medicine patients at CRISPRMED25 | New confirmed speakers and sponsors | Who will you meet at CRISPRMED25?

Meet one of the first CRISPR Medicine patients at CRISPRMED25 | New confirmed speakers and sponsors | Who will you meet at CRISPRMED25?


Save the dates!

  • April 7th, 2025 - CRISPRMED25 Virtual Event
  • April 8th -11th, 2025 - CRISPRMED25 In-person Scientific Conference
  • April 8th, 2025 - Startup-Investor Event (Invest in Future CRISPR Medicine | Develop Future Medicine | B2B networking | Investors and early-phase startups)


Important deadlines:

  • July 1st 2024: Registration & abstract submission opens (register here)
  • January 3rd 2025: Early bird registration deadline
  • January 17th 2025: Abstract submission deadline
  • February 28th 2025: Oral and poster notifications & final programme available
  • March 3rd 2025: Travel grant notification
  • April 4th 2025: Registration deadline in-person event
  • April 4th 2025: Registration deadline virtual event
  • April 7th 2025: Abstract publication in the CRISPR Medicine News portal


Meet one of the first CRISPR Medicine patients at CRISPRMED25

Jimi Olaghere is a CASGEVY recipient who has developed a keen interest in the advancements of cell and gene therapies, since his transformative participation in the groundbreaking clinical trial.

Jimi is passionate about the positive impact that these therapies can have on patients in need and has become a staunch advocate for increased accessibility of gene therapies for sickle cell disease patients worldwide.

At CRISPRMED25, Jimi will share his story about living with sickle cell disease, before and after treatment with the recently approved CRISPR therapy CASGEVY.


CRISPRMED25 Invited Speakers (early confirmation)

Scientific Conference, April 8-11th, 2025 (register here)

Meet the CRISPRMED25 Speakers


Keynote Speaker:

Virginijus Šikšnys, Prof., Ph.D., Head of Department, Vilnius University, Lithuania


  • Jakob Giehm Mikkelsen, Prof., Ph.D., Aarhus University, Denmark
  • Annarita Miccio, Group Leader, Ph.D., Imagine Institute of Genetic Diseases, France
  • Matthew Porteus, Prof., MD, Ph.D., Stanford Medicine, US
  • Raffaella Di Micco, Group Leader, Ph.D., SR-TIGET, Italy
  • Jacob Corn, Prof., Ph.D., ETH Zürich, Switzerland
  • Gerald Schwank, Prof., Ph.D., University of Zürich, Switzerland
  • Julian Grünewald, Ass. Prof., MD, Ph.D., Technical University of Munich, Germany
  • William H. Peranteau, MD, Surgeon and Professor, University of Pennsylvania/Children’s Hospital of Philadelphia, US
  • Guillermo Montoya, Prof., Research Director and Group Leader at the Protein Structure and Function program at CPR, University of Copenhagen, Denmark
  • Kiana Aran, Ass. Prof. of Bioengineering and Medicine, University of California San Diego, US
  • Suk See De Ravin, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US
  • Xavier Duportet, PhD, Co-founder and CEO, Eligo Biosciences, France
  • Rasmus O. Bak, Ass. Prof. and Group Leader, Aarhus University, Denmark
  • Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
  • Ayal Hendel, Principal Investigator and Group Leader, Bar-Ilan University, Israel
  • Alessia Cavazza, Ass. Prof., Group Leader, Infection, Immunity & Inflammation Department at University College London's Great Ormond Street Institute of Child Health, England
  • Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
  • Life Edit Therapeutics, US
  • ReCode Therapeutics, US
  • ...


Startup-Investor Event, April 8th, 2025 (register here)


CRISPRMED25 Sponsors (early confirmation)



Are you a student?

As a student/young researcher, you can register for one of the CRISPRMED25/GenE-HumDi COST Action workshops. The workshops will be facilitated by scientific leaders from the GenE-HumDi consortium. The workshop registration is included in the registration fee and there will only be 30 seats available per workshop.



Are you a founder?

The CRISPRMED25 Startup-Investor Event, April 8th, 2025, will connect founders within the CRISPR field with relevant investors and business development people. As a founder you can reserve one of the 15 presentation slots available at this event (included in the registration fee). Register here to reserve one of the speaker slots.

Invest in Future CRISPR Medicine | Develop Future Medicine


CRISPRMED25 Attending Institutions and Companies (early confirmation)



To view or add a comment, sign in

Insights from the community

Others also viewed

Explore topics